QUT ePrints

Browse By Person: Doggrell, Sheila

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Jump to: 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014
Number of items: 161.

2005

Doggrell, Sheila (2005) Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding. Expert Opinion on Pharmacotherapy, 6(7), pp. 1253-1256.
Number of citations in Scopus 6
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) BG-9928 (Biogen Idec). Current Opinion in Investigational Drugs, 6(9), pp. 962-968.
Number of citations in Scopus 9

Doggrell, Sheila (2005) BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia. Expert Opinion on Investigational Drugs, 14(1), pp. 89-91.
Number of citations in Scopus 29
Number of citations in Web of Science® 25

Doggrell, Sheila (2005) Berberine - a novel approach to cholesterol lowering. Expert Opinion on Investigational Drugs, 14(5), pp. 683-685.
Number of citations in Scopus 27
Number of citations in Web of Science® 25

Doggrell, Sheila (2005) Bradykinin B2 receptors - a target in diabetic nephropathy. Expert Opinion on Therapeutic Targets, 9(2), pp. 411-414.
Number of citations in Scopus 5
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) CHARMed - the effects of candesartan in heart failure. Expert Opinion on Pharmacotherapy, 6(3), pp. 513-516.
Number of citations in Scopus 2

Doggrell, Sheila (2005) CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. Expert Opinion on Pharmacotherapy, 6(10), pp. 1761-1764.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Calmodulin kinase II as a target for inhibition in cardiac disease. Expert Opinion on Therapeutic Targets, 9(6), pp. 1319-1321.

Doggrell, Sheila & Wanstall, Janet (2005) Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors. Canadian Journal of Physiology and Pharmacology, 83(2), pp. 123-130.
Number of citations in Scopus 30
Number of citations in Web of Science® 22

Doggrell, Sheila (2005) Clinical evidence for drug treatments in obesity in hypertensive patients. Methods and Findings in Experimental and Clinical Pharmacology, 27(2), pp. 119-125.
Number of citations in Scopus 4
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Clinical potential of nitric oxide-independent soluble guanylate cyclase activators. Current Opinion in Investigational Drugs, 6(9), pp. 874-878.
Number of citations in Scopus 11

Doggrell, Sheila (2005) Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opinion on Pharmacotherapy, 6(1), pp. 75-84.
Number of citations in Scopus 30
Number of citations in Web of Science® 23

Doggrell, Sheila (2005) Conivaptan (Yamanouchi). Current Opinion in Investigational Drugs, 6(3), pp. 317-326.
Number of citations in Scopus 7

Doggrell, Sheila (2005) Cytochrome P-450: a new target in the heart and coronary circulation. Drugs of the Future, 30(3), pp. 261-269.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Wanstall, Janet, Homer, Kerry, & Doggrell, Sheila (2005) Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Current Vascular Pharmacology, 3(1), pp. 41-53.
Number of citations in Scopus 50

Doggrell, Sheila (2005) Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease. Expert Opinion on Investigational Drugs, 14(4), pp. 535-538.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Fluoxetine - do the benefits outweigh the risks in adolescent major depression? Expert Opinion on Pharmacotherapy, 6(1), pp. 147-150.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved? Expert Opinion on Pharmacotherapy, 6(5), pp. 831-834.
Number of citations in Scopus 5
Number of citations in Web of Science® 1

Doggrell, Sheila & Hancox, Jules (2005) Ibutilide - recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opinion on Investigational Drugs, 14(5), pp. 655-669.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia? Expert Opinion on Investigational Drugs, 14(8), pp. 1063-1066.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? Expert Opinion on Pharmacotherapy, 6(12), pp. 2141-2144.

Doggrell, Sheila (2005) More support for high-dose atorvastatin in coronary artery disease. Expert Opinion on Pharmacotherapy, 6(13), pp. 2365-2368.

Doggrell, Sheila (2005) NF-(kappa)B - a target in the inflammation of bone destruction. Expert Opinion on Therapeutic Targets, 9(1), pp. 191-193.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Neuromedin U - a new target in obesity. Expert Opinion on Therapeutic Targets, 9(4), pp. 875-877.
Number of citations in Scopus 7
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) New drugs being developed for the treatment of tuberculosis. Expert Opinion on Investigational Drugs, 14(7), pp. 917-920.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. Expert Opinion on Pharmacotherapy, 6(8), pp. 1421-1423.
Number of citations in Scopus 32
Number of citations in Web of Science® 27

Doggrell, Sheila (2005) Phosphodiesterase 5A as a target in cardiac disease. Expert Opinion on Therapeutic Targets, 9(5), pp. 1097-1100.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours. Expert Opinion on Investigational Drugs, 14(12), pp. 1561-1564.

Doggrell, Sheila (2005) Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opinion on Pharmacotherapy, 6(14), pp. 2535-2539.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Recent findings with docetaxel in postoperative treatment for breast cancer. Expert Opinion on Pharmacotherapy, 6(16), pp. 2903-2906.

Doggrell, Sheila (2005) Recent important trials of pharmacotherapy in Parkinson's disease. Expert Opinion on Pharmacotherapy, 6(6), pp. 1025-1028.

Doggrell, Sheila (2005) Relating statin therapy to C-reactive protein levels. Expert Opinion on Pharmacotherapy, 6(9), pp. 1597-1600.
Number of citations in Scopus 7
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) Rho-kinase inhibitors show promise in pulmonary hypertension. Expert Opinion on Investigational Drugs, 14(9), pp. 1157-1159.
Number of citations in Scopus 19
Number of citations in Web of Science® 15

Doggrell, Sheila (2005) Stabilisation of calstabin2 - a new approach in sudden cardiac death. Expert Opinion on Therapeutic Targets, 9(5), pp. 955-962.
Number of citations in Scopus 4
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Taking the 20-HETE out of the cardiovascular system: The potential of 20-HETE synthesis inhibitors. Current Opinion in Investigational Drugs, 6(9), pp. 901-906.
Number of citations in Scopus 2

Doggrell, Sheila (2005) Which drug combination for hormone-refractory prostate cancer? Expert Opinion on Pharmacotherapy, 6(4), pp. 667-670.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opinion on Investigational Drugs, 14(3), pp. 339-342.
Number of citations in Scopus 12
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) Ximelagatran - recent comparisons with warfarin. Expert Opinion on Pharmacotherapy, 6(11), pp. 1943-1946.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2005) The nitrosterols - a step forward from the steroid anti-inflammatory drugs? Expert Opinion on Investigational Drugs, 14(7), pp. 823-828.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) The safety of lumiracoxib when used in the treatment of arthritis. Expert Opinion on Pharmacotherapy, 6(2), pp. 347-350.
Number of citations in Scopus 8
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) A small-molecule lead compound for the treatment of Alzheimer's disease. Expert Opinion on Investigational Drugs, 14(2), pp. 199-201.

2006

Doggrell, Sheila (2006) After the failure of citalopram for depression, what next? Expert Opinion on Pharmacotherapy, 7(11), pp. 1515-1518.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) Bradykinin B2 receptors as a target in diabetic nephropathy. Current Opinion in Investigational Drugs, 7(3), pp. 251-255.
Number of citations in Scopus 4

Doggrell, Sheila (2006) Ceramide as a target in emphysema. Expert Opinion on Therapeutic Targets, 10(1), pp. 191-194.

Doggrell, Sheila (2006) Inhibition of RANKL: a new approach to the treatment of osteoporosis. Expert Opinion on Pharmacotherapy, 7(8), pp. 1097-1100.
Number of citations in Scopus 2

Doggrell, Sheila (2006) Inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery disease. Expert Opinion on Investigational Drugs, 15(2), pp. 99-106.
Number of citations in Scopus 16
Number of citations in Web of Science® 11

Doggrell, Sheila (2006) Is NXY-059 an advancement in the treatment of acute ischaemic stroke? Expert Opinion on Pharmacotherapy, 7(7), pp. 965-968.

Doggrell, Sheila (2006) Is amlodipine the best initial monotherapy for hypertension? Expert Opinion on Pharmacotherapy, 7(6), pp. 829-832.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Is exenatide advancing the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(1), pp. 109-112.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(9), pp. 1229-1233.
Number of citations in Scopus 4
Number of citations in Web of Science® 5

Doggrell, Sheila (2006) Natalizumab in multiple sclerosis: proceed with caution? Expert Opinion on Pharmacotherapy, 7(12), pp. 1675-1678.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) New targets in and potential treatments for cholesterol gallstone disease. Current Opinion in Investigational Drugs, 7(4), pp. 344-348.
Number of citations in Scopus 8
Number of citations in Web of Science® 5

Doggrell, Sheila (2006) Nitrone spin on cerebral ischemia. Current Opinion in Investigational Drugs, 7(1), pp. 20-24.
Number of citations in Scopus 4
Number of citations in Web of Science® 4

Doggrell, Sheila (2006) Partial agonism at nicotinic receptors with varenicline - a new approach to smoking cessation. Expert Opinion on Pharmacotherapy, 7(18), pp. 2599-2603.
Number of citations in Scopus 1

Doggrell, Sheila (2006) Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Expert Opinion on Pharmacotherapy, 7(4), pp. 485-488.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Phosphoinositide 3-kinase-gamma as a target in rheumatoid arthritis and systemic lupus. Expert Opinion on Therapeutic Targets, 10(4), pp. 627-630.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Recent evidence of sustained benefit with exenatide in Type 2 diabetes. Expert Opinion on Pharmacotherapy, 7(14), pp. 2003-2006.
Number of citations in Scopus 6
Number of citations in Web of Science® 6

Doggrell, Sheila (2006) Sibutramine for obesity in adolescents. Expert Opinion on Pharmacotherapy, 7(17), pp. 2435-2438.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) 'Simply stunning' - trastuzumab in HER2-positive breast cancer. Expert Opinion on Pharmacotherapy, 7(5), pp. 631-634.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert Opinion on Pharmacotherapy, 7(2), pp. 225-228.
Number of citations in Scopus 2

Doggrell, Sheila (2006) Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention? Expert Opinion on Pharmacotherapy, 7(15), pp. 2169-2173.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

2007

Doggrell, Sheila (2007) Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target? Current Opinion in Investigational Drugs, 8(9), pp. 742-749.
Number of citations in Scopus 5
Number of citations in Web of Science® 5

Doggrell, Sheila (2007) Clopidogrel use with stenting. Expert Opinion on Pharmacotherapy, 8(9), pp. 1399-1402.
Number of citations in Scopus 1
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction? International Journal of Impotence Research, 19(3), pp. 281-295.
Number of citations in Scopus 21
Number of citations in Web of Science® 13

Doggrell, Sheila (2007) Does rosiglitazone increase cardiovascular outcomes? Expert Opinion on Pharmacotherapy, 8(15), pp. 2665-2669.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Is fingolimod an advancement in the treatment of multiple sclerosis? Expert Opinion on Pharmacotherapy, 8(3), pp. 383-386.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2007) Misoprostol for the treatment of early pregnancy failure. Current Clinical Pharmacology, 2(1), pp. 1-9.
Number of citations in Scopus 3

Doggrell, Sheila (2007) Novel drugs and products in neuroscience: highlights from IBRO. Drugs of the Future, 32(11), pp. 1007-1017.

Doggrell, Sheila (2007) Rosiglitazone: rosy news for a thiazolidinedione. Expert Opinion on Pharmacotherapy, 8(2), pp. 265-268.
Number of citations in Scopus 1

2008

Doggrell, Sheila (2008) What is the future for rimonabant in the treatment of obesity. Review of Endocrinology, December, pp. 14-17.

Doggrell, Sheila (2008) Celecoxib to prevent restenosis - results from the COREA-TAXUS trial. Expert Opinion on Pharmacotherapy, 9(2), pp. 339-341.

Doggrell, Sheila (2008) Clinical trials with thiazolidinediones in subjects with Type 2 diabetes - is pioglitazone any different from rosiglitazone? Expert Opinion on Pharmacotherapy, 9(3), pp. 405-420.
Number of citations in Scopus 14
Number of citations in Web of Science® 11

Doggrell, Sheila (2008) Is long-term adjuvant treatment of breast cancer with anastrozole indicated? Expert Opinion on Pharmacotherapy, 9(9), pp. 1619-1622.
Number of citations in Scopus 3
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Is rimonabant efficacious and safe in the treatment of obesity? Expert Opinion on Pharmacotherapy, 9(15), pp. 2727-2731.
Number of citations in Scopus 15
Number of citations in Web of Science® 14

Doggrell, Sheila (2008) Is sapropterin treatment suitable for all subjects with phenylketonuria? Expert Opinion on Pharmacotherapy, 9(1), pp. 145-147.
Number of citations in Scopus 5
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Is tocilizumab an option for the treatment of arthritis? Expert Opinion on Pharmacotherapy, 9(11), pp. 2009-2013.

Doggrell, Sheila (2008) New indications for topiramate: alcohol dependency and binge-eating disorder. Expert Opinion on Pharmacotherapy, 9(5), pp. 869-873.
Number of citations in Scopus 3
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Therapeutic potential of non-peptide chymase inhibitors. Expert Opinion on Therapeutic Patents, 18(5), pp. 485-499.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

2009

Doggrell, Sheila (2009) Is liraglutide or exenatide better in type 2 diabetes? Expert Opinion on Pharmacotherapy, 10(16), pp. 2769-2772.
Number of full-text downloads 489
Number of citations in Scopus 2

Doggrell, Sheila (2009) Anti-cancer activity of zoledronic acid in breast cancer. Expert Opinion on Pharmacotherapy, 10(14), pp. 2387-2390.

Doggrell, Sheila (2009) Clinical efficacy and safety of zoledronic acid in osteoporosis and Paget's disease. Expert Review of Endocrinology and Metabolism, 4(5), pp. 405-415.

Doggrell, Sheila (2009) Clinical efficacy and safety of zoledronic acid in prostate and breast cancer. Expert Review of Anticancer Therapy, 9(9), pp. 1211-1218.
Number of full-text downloads 263
Number of citations in Scopus 10
Number of citations in Web of Science® 7

Doggrell, Sheila (2009) Good clinical endpoints with denosumab in osteoporosis and cancer. Expert Opinion in Pharmacotherapy, 10(17), pp. 2939-2943.
Number of full-text downloads 131

Doggrell, Sheila (2009) Lyprinol : is it a useful anti-inflammatory agent? Evidence Based Complementary and Alternative Medicine.
Number of full-text downloads 434
Number of citations in Scopus 3

Doggrell, Sheila (2009) New findings with old drugs for osteoporosis. Expert Opinion on Pharmacotherapy, 10(3), pp. 513-516.
Number of full-text downloads 132
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2009) Telcagepant is a new oral treatment for migraine. Expert Opinion in Pharmacotherapy, 10(9), pp. 1523-1526.
Number of full-text downloads 193
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2009) Tesofensine : a novel potent weight loss medicine. Expert Opinion in Investigational Drugs, 18(7), pp. 1043-1046.
Number of full-text downloads 233
Number of citations in Scopus 6
Number of citations in Web of Science® 5

2010

Doggrell, Sheila Anne (2010) Resolvin inflammation with pain. Expert Opinion on Investigational Drugs, 19(11), pp. 1461-1464.
Number of full-text downloads 101
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2010) Oral fingolimod for relapsing-remitting multiple sclerosis. Expert Opinion on Pharmacotherapy, 11(10), pp. 1777-1781.
Number of full-text downloads 14
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2010) Zoledronic acid once-yearly : what role in the prevention of non-vertebral osteoporotic fractures? Clinical Medicine Insights: Therapeutics, 2010(2), pp. 539-547.
Number of full-text downloads 317

Doggrell, Sheila Anne (2010) The hedgehog pathway inhibitor GDC-0449 shows potential in skin and other cancers. Expert Opinion on Investigational Drugs, 19(3), pp. 451-454.
Number of full-text downloads 175
Number of citations in Scopus 9
Number of citations in Web of Science® 8

Doggrell, Sheila (2010) Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes? Diabetic Medicine: journal of diabetes UK, 27(12), pp. 1341-1349.
Number of citations in Scopus 2

Doggrell, Sheila Anne & Christensen, Anne-Marie (2010) Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis? Expert Opinion on Pharmacotherapy, 11(14), pp. 2437-2442.
Number of full-text downloads 95
Number of citations in Scopus 1

Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes. Expert Opinion on Pharmacotherapy, 11(2), pp. 325-329.
Number of full-text downloads 171

Hancox, Jules & Doggrell, Sheila (2010) Perspective: Does ranolazine have potential for the treatment of atrial fibrillation? Expert Opinion on Investigational Drugs, 19(12), pp. 1465-1474.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

2011

Doggrell, Sheila (2011) Adherence to oral endocrine treatments in women with breast cancer: can it be improved? Breast Cancer Research and Treatment, 129(2), pp. 299-308.
Number of citations in Scopus 7
Number of citations in Web of Science® 6

Doggrell, Sheila & Christensen, Anne-Marie (2011) Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Expert Opinion on Pharmacotherapy, 12(1), pp. 157-163.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2011) Bitter taste receptors as a target for bronchodilation. Expert Opinion on Therapeutic Targets, 15(7), pp. 899-902.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2011) CX3CR1 as a target for airways inflammation. Expert Opinion on Therapeutic Targets, 15(9), pp. 1139-1142.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2011) Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease? Reviews on Recent Clinical Trials, 6(2), pp. 147-157.
Number of citations in Scopus 2

Doggrell, Sheila (2011) Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer. Expert Opinion on Therapeutic Targets, 15(12), pp. 1419-1422.

Doggrell, Sheila (2011) Lowering LDL cholesterol with margarine containing plant stanol/sterol esters: Is it still relevant in 2011? Complementary Therapies in Medicine, 19(1), pp. 37-46.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2011) Sitagliptin or exenatide once weekly for type 2 diabetes: Comparison of the clinical trials. Expert Opinion on Pharmacotherapy, 12(13), pp. 2055-2067.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila A. & Polkinghorne, Adam (2011) A Strategy for supporting students given Advanced Standing into Nursing. In Thomas, Jason (Ed.) 14th Pacific Rim First Year in Higher Education Conference 2011 : Design for Student Success, Colourwise Reproductions, Freemantle, Western Australia.
Number of full-text downloads 15

Doggrell, Sheila (2011) Treatment for relapsed Hodgkin lymphoma: Refinement of chemotherapy or targeted treatment? Expert Opinion on Pharmacotherapy, 12(6), pp. 991-994.

Doggrell, Sheila (2011) A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2. Expert Opinion on Investigational Drugs: authoritative analysis of R&D trends, 20(4), pp. 587-590.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

2012

Doggrell, Sheila Anne & Chan, Vincent (2012) Bariatric surgery or medicine for type 2 diabetes? Expert Opinion on Pharmacotherapy, 13(15), pp. 2249-2253.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila A. (2012) More light at the end of the tunnel – apixaban in atrial fibrillation. Expert Opinion in Investigational Drugs, 21(8), pp. 1235-1239.
Number of full-text downloads 91
Number of citations in Scopus 1

Doggrell, Sheila, Davis, Elizabeth, Hart, Joanne, Hinton, Tina, Johnson, Graham, & Mullaney, Ian (2012) Pharmacology in one semester. Sheila Doggrell.
Number of full-text downloads 413

Doggrell, Sheila Anne, Schaffer, Sally, & Dallemagne, Catherine (2012) Transferring a successful strategy for supporting accelerated nursing students from a small to a large cohort. In Nelson, Karen J. & Kift, Sally M. (Eds.) 15th International First Year in Higher Education Conference : New Horizons, 26-29 June 2012, Sofitel Brisbane Central, Brisbane, QLD.
Number of full-text downloads 49

Doggrell, Sheila & Hancox, Jules (2012) PALLAS : limiting indications for dronedarone treatment of atrial fibrillation. Expert Opinion on Pharmacotherapy, 13(6), pp. 867-871.
Number of full-text downloads 22
Number of citations in Web of Science® 1

Doggrell, Sheila (2012) Dalcetrapib restoring belief in modulating CETP as a beneficial mechanism in cardiovascular disease. Expert Opinion in Investigational Drugs, 21(4), pp. 569-573.
Number of full-text downloads 73
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila & Davis, Elisabeth (2012) Anti-infectives. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
Number of full-text downloads 77

Doggrell, Sheila (2012) Drug development. In Phamacology in one semester. Doggrell, Sheila.
Number of full-text downloads 41

Doggrell, Sheila (2012) Drug distribution, metabolism and elimination, and relationship to blood levels. In Doggrell, Sheila (Ed.) Pharmacology in one semester. eBook.
Number of full-text downloads 89

Doggrell, Sheila & Hart, Joaane L. (2012) Drugs Used to Treat Endocrine Disorders. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 143

Doggrell, Sheila (2012) Drugs and local chemical mediators. Pharmacology in One Semester.
Number of full-text downloads 72

Doggrell, Sheila (2012) Drugs and neurotransmitters. Pharmacology in One Semester.
Number of full-text downloads 88

Doggrell, Sheila (2012) Drugs and the autonomic nervous system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 116

Doggrell, Sheila (2012) Drugs and the gastrointestinal tract. Pharmacology in One Semester. (Unpublished)
Number of full-text downloads 146

Doggrell, Sheila (2012) Drugs and the respiratory system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 141

Doggrell, Sheila (2012) Drugs and the somatic nervous system. Pharmacology in One Semester.
Number of full-text downloads 42

Doggrell, Sheila (2012) Drugs for cardiac arrhythmmias, antithrombotic drugs and lipid modulating drugs. Pharmacology in one semester.
Number of full-text downloads 48

Doggrell, Sheila (2012) Drugs for diabetes and obesity. Pharmacology in one semester.
Number of full-text downloads 60

Doggrell, Sheila (2012) Drugs for hypertension, angina and heart failure. Pharmacology in One Semester.
Number of full-text downloads 147

Doggrell, Sheila (2012) Introduction to pharmacology, and routes of drug administration. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Sheila Doggrell.
Number of full-text downloads 304

Doggrell, Sheila & Kairuz, Therese (2012) Medicine management by the older-aged living independently in different types of retirement villages. Journal of Pharmacy Practice and Research, 42, pp. 208-212.
Number of full-text downloads 99
Number of citations in Scopus 2

Doggrell, Sheila (2012) Neurological drugs and opioids for pain management. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
Number of full-text downloads 77

Doggrell, Sheila (2012) Pharmacodynamics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 75

Doggrell, Sheila (2012) Pharmacovigilance and pharmacogenetics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 72

Doggrell, Sheila (2012) Poisoning with drugs. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
Number of full-text downloads 35

Doggrell, Sheila (2012) Smoking cessation. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
Number of full-text downloads 52

Doggrell, Sheila A. (2012) Writing eBooks to support first year students. In First Year in Higher Education Conference, 6 July 2007, Queensland University of Technology, Brisbane, Queensland, Australia.
Number of full-text downloads 69

Doggrell, Sheila (2012) The ezetimibe controversy? Can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Expert Opinion on Pharmacotherapy, 13(10), pp. 1469-1480.
Number of full-text downloads 101
Number of citations in Scopus 7
Number of citations in Web of Science® 9

Polkinghorne, Adam & Doggrell, Sheila (2012) A successful strategy for supporting low socioeconomic and accelerated students studying Biosciences in their first year of study. In Mortimer, Rachel (Ed.) 15th International First Year in Higher Education Conference 2012 : New Horizons, 26 - 29 June 2012, Sofitel Brisbane Central, Brisbane, Queensland, Australia.
Number of full-text downloads 24

2013

Doggrell, Sheila Anne (2013) Comment on: Clinical benefits of ezetimibe : absence of proof is just that. Expert Opinion on Pharmacotherapy, 14(18), pp. 2611-2613.
Number of full-text downloads 20

Doggrell, Sheila Anne (2013) Inadequate management of medicines by the older-aged living in a retirement village. International Journal of Clinical Pharmacy, 35(4), pp. 546-549.
Number of full-text downloads 1
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila A & Hancox, Jules C (2013) Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia. Expert Opinion on Drug Safety, 12(3), pp. 421-431.
Number of full-text downloads 22
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila A (2013) Exenatide extended-release; clinical trials, patient preference, and economic considerations. Patient Preference and Adherence, 7, pp. 35-45.
Number of full-text downloads 82
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Schaffer, Sally, Doggrell, Sheila, & Polkinghorne, Adam (2013) Continuing success of a strategy to support accelerated nursing students at two diverse campuses. In First Year Higher Education (FYHE 2013), 7-10 July 2013, Museum of New Zealand Te Papa Tongarewa, Wellington.
Number of full-text downloads 14

Doggrell, Sheila A., Schaffer, Sally, & Polkinghorne, Adam (2013) Surviving Bioscience and Pharmacology – an eBook for accelerated students in Nursing. In 16th International First Year Higher Education Conference 2013, 7-10 July 2013, Museum of New Zealand Te Papa Tongarewa, Wellington, New Zealand.
Number of full-text downloads 62

2014

Doggrell, Sheila A. & Tuli, Rinku (2014) Dapagliflozin – do we need it registered for type 2 diabetes? Expert Opinion on Pharmacotherapy, 15(11), pp. 1631-1635.

Doggrell, Sheila A (2014) Not so critical appraisal of dapagliflozin. Patient Preference and Adherence, 8, pp. 1101-1104.
Number of full-text downloads 11

Schaffer, Sally, Doggrell, Sheila, Polkinghorne, Adam, & Tuli, Rinku (2014) A loss of bioscience knowledge in nursing students. In ANZAHPE 2014 Annual Conference of the Australian and New Zealand Association for Health Professional Educators, 7-10 July 2014, Gold Coast, Australia. (Unpublished)
Number of full-text downloads 4

Doggrell, Sheila, Schaffer, Sally, Polkinghorne, Adam, & Tuli, Rinku (2014) Do nursing students have the recall of bioscience necessary to study pharmacology? In 17th World Congress of Basic and Clinical Pharmacology (WCP2014), 13-18 July 2014, Cape Town, South Africa.

Doggrell, S. A. & Chan, V. (2014) Do interventions by allied health professionals discussing adherence to insulin improve this adherence? Diabetes research and clinical practice, 104(3), e61-e63.
Number of full-text downloads 4

Doggrell, Sheila & Warot, Servane (2014) The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. International journal of clinical pharmacy, 36(3), pp. 488-497.

Doggrell, Sheila A. & Dimmitt, Simon B. (2014) Gliptins - do they increase cardiovascular risk or benefit? Expert opinion in drug safety, 13(5), pp. 675-680.

Doggrell, Sheila A. (2014) Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin. Patient Preference and Adherence, 2014(8), pp. 473-475.
Number of full-text downloads 3
Number of citations in Web of Science® 1

Doggrell, Sheila & McIntyre, Kerry (2014) Canagliflozin : something new for type 2 diabetes, but is it safe and efficacious? Expert Opinion on Pharmacotherapy, 15(3), pp. 437-441.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila A & Hancox, Jules C (2014) Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine. Expert Opinion on Drug Safety, 13(1), pp. 131-138.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila & Kairuz, Therese (2014) Comparative studies of how living circumstances influence medication adherence in >65 year olds. International Journal of Clinical Pharmacy, 36(1), pp. 30-35.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

This list was generated on Sat Dec 20 05:48:47 2014 AEST.